NO20035282L - Anvendelse av polyklonale immunglobuliner - Google Patents

Anvendelse av polyklonale immunglobuliner

Info

Publication number
NO20035282L
NO20035282L NO20035282A NO20035282A NO20035282L NO 20035282 L NO20035282 L NO 20035282L NO 20035282 A NO20035282 A NO 20035282A NO 20035282 A NO20035282 A NO 20035282A NO 20035282 L NO20035282 L NO 20035282L
Authority
NO
Norway
Prior art keywords
polyclonal immunoglobulins
immunoglobulins
polyclonal
Prior art date
Application number
NO20035282A
Other languages
English (en)
Norwegian (no)
Other versions
NO20035282D0 (no
Inventor
Hans Loibner
Gottfried Himmler
Original Assignee
Igeneon Krebs Immuntherapie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs Immuntherapie filed Critical Igeneon Krebs Immuntherapie
Publication of NO20035282D0 publication Critical patent/NO20035282D0/no
Publication of NO20035282L publication Critical patent/NO20035282L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20035282A 2001-06-01 2003-11-27 Anvendelse av polyklonale immunglobuliner NO20035282L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0086001A AT410637B (de) 2001-06-01 2001-06-01 Verwendung von polyklonalen immunglobulinen
PCT/AT2002/000088 WO2002096455A2 (de) 2001-06-01 2002-03-19 Verwendung von polyklonalen immunglobulinen als impfstoff

Publications (2)

Publication Number Publication Date
NO20035282D0 NO20035282D0 (no) 2003-11-27
NO20035282L true NO20035282L (no) 2003-11-27

Family

ID=3682339

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035282A NO20035282L (no) 2001-06-01 2003-11-27 Anvendelse av polyklonale immunglobuliner

Country Status (16)

Country Link
US (1) US20040151717A1 (cs)
EP (1) EP1399185A2 (cs)
JP (1) JP2004532261A (cs)
CN (1) CN1512895A (cs)
AT (1) AT410637B (cs)
AU (1) AU2002242447B2 (cs)
BR (1) BR0210239A (cs)
CA (1) CA2449026A1 (cs)
CZ (1) CZ20033273A3 (cs)
HU (1) HUP0400031A3 (cs)
IL (2) IL158950A0 (cs)
MX (1) MXPA03010829A (cs)
NO (1) NO20035282L (cs)
PL (1) PL367835A1 (cs)
SK (1) SK14662003A3 (cs)
WO (1) WO2002096455A2 (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10127712A1 (de) * 2001-06-07 2002-12-19 Torsten Witte Anwendung von IgM-Antikörpern gegen dsDNA beim systemischen Lupus erythematodes mit Nephritis
WO2005023867A1 (en) * 2003-09-08 2005-03-17 Medical Research Council Method for the treatment or prophylaxis of tuberculosis
ES2988823T3 (es) * 2014-12-03 2024-11-21 Csl Behring Ag Producto farmacéutico con mayor estabilidad que comprende inmunoglobulinas
FR3072880A1 (fr) * 2017-10-30 2019-05-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Formulation liposomale et son utilisation en therapie anti-tumorale

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3340487A1 (de) * 1983-11-09 1985-05-15 Sandoz-Patent-GmbH, 7850 Lörrach Neue therapeutische verwendung
EP0438803B1 (en) * 1990-01-26 1997-03-12 Immunomedics, Inc. Vaccines against cancer and infectious diseases
JP2795289B2 (ja) * 1990-09-04 1998-09-10 富士通株式会社 電子機器におけるプリント板ユニットの保持構造
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
WO1992015885A1 (en) * 1991-03-11 1992-09-17 Idec Pharmaceuticals Corporation Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations
US5562902A (en) * 1994-03-14 1996-10-08 Arp Biomed, Inc. Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
US6462187B1 (en) * 2000-06-15 2002-10-08 Millennium Pharmaceuticals, Inc. 22109, a novel human thioredoxin family member and uses thereof
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma
AT409086B (de) * 1999-11-16 2002-05-27 Igeneon Krebs Immuntherapie Neue verwendung von antikörpern als impfstoffe
AT410636B (de) * 2001-03-23 2003-06-25 Igeneon Krebs Immuntherapie Verfahren zur herstellung eines impfstoffes

Also Published As

Publication number Publication date
NO20035282D0 (no) 2003-11-27
HUP0400031A2 (hu) 2004-04-28
US20040151717A1 (en) 2004-08-05
MXPA03010829A (es) 2004-02-17
ATA8602001A (de) 2002-11-15
CA2449026A1 (en) 2002-12-05
WO2002096455A3 (de) 2003-12-24
AU2002242447B2 (en) 2007-11-08
CN1512895A (zh) 2004-07-14
EP1399185A2 (de) 2004-03-24
BR0210239A (pt) 2004-03-30
HUP0400031A3 (en) 2006-03-28
JP2004532261A (ja) 2004-10-21
IL158950A0 (en) 2004-05-12
SK14662003A3 (sk) 2004-05-04
PL367835A1 (en) 2005-03-07
AT410637B (de) 2003-06-25
CZ20033273A3 (en) 2004-07-14
WO2002096455A2 (de) 2002-12-05
IL158950A (en) 2008-04-13

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
DE60233399D1 (de) Erzerrung zweiter ordnung
IS6982A (is) Mótefni gegn VLA-1
DE60236226D1 (de) Verbesserung der Altersweitsichtigkeit
EP1359864A4 (en) IRRADIATED STENT COVER
NO20022625L (no) Testing av åpen brönnformasjon
DK1438306T3 (da) Derivater af UK-2A
DE50212455D1 (de) Verwendung von Dimerdiolen
DE50208287D1 (de) Bicyclische n-arylamide
FI20010558A0 (fi) Kappaleiden paikannus
NO20042667L (no) Fremgangsmate for fremstilling av escitalopram
NO20041968L (no) Anvendelse av cystationin
PT1429926E (pt) Circuito de interligacao
EP1445096A4 (en) IMPACT-RESISTANT FILM
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
NO20035282L (no) Anvendelse av polyklonale immunglobuliner
ITMC20010025U1 (it) Doccia multifunzionale
FI20012295A0 (fi) Hyvyysluku
ITMI20020900A0 (it) Soffietto
AU2002242447A1 (en) Use of polyclonal immunoglobulins
FI20011055L (fi) Heveiiniä sitovat monoklonaaliset vasta-aineet
DE60232564D1 (de) Fixiergerät
DE60121724D1 (de) Einschichtiges elektrophotographisches Element
ATE354561T1 (de) Substituierte 1-aryl-but-3-enylamin- und 1-aryl- but-2-enylaminverbindungen
DE50209377D1 (de) Nachweis humaner auto-antikörper

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application